ANNEE 2015

Publié le 30/03/2018 à 15h48

Abadie D, Rousseau V, Logerot S, Cottin J, Montastruc JL, Montastruc F. Serotonin Syndrome : Analysis of Cases Registered in the French Pharmacovigilance Database. J Clin Psychophar. 2015 ;35:382-8.

Abadie D, Hurault-Delarue C, Damase-Michel C, Montastruc JL, Lacroix I. Medication exposure and spontaneous abortion : a case-control study using a French medical database. Clin Exp Obstet Gynecol. 2015 ;42:431-6.

Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F ; EMIR Study Group on behalf of the French network of pharmacovigilance centres. Incidence of hospital admissions due to adverse drug reactions in France : the EMIR study. Fundam Clin Pharmacol. 2015 ;29:106-11.

Bernard N, Jantzem H, Becker M, Pecriaux C, Bénard-Laribière A, Montastruc JL, Descotes J, Vial T ; French Network of Regional Pharmacovigilance Centres. Severe adverse effects of bromocriptine in lactation inhibition : a pharmacovigilance survey. BJOG. 2015 ;122:1244-51.

Berreni A, Montastruc F, Bondon-Guitton E, Rousseau V, Abadie D, Durrieu G, Chebane L, Giroud JP, Bagheri H, Montastruc JL. Adverse drug reactions to self-medication : a study in a pharmacovigilance database. Fundam Clin Pharmacol. 2015 Oct ;29(5):517-20.

Chayé H, Bernard M, Tubéry M, Rousseau V, Ecoiffier M, Montastruc JL, Bagheri H. Hospital readmission induced by adverse drug reaction : A pilot study in a post-emergency unit of a French university hospital. Rev Med Interne. 2015 ;36:450-6.

Chebane L, Bagheri H, Hillaire-Buys D, Géniaux H, Yahioui N, Laroche ML, Cottin J, Spreux A, Mosquet B, Pecriaux C, Bellet F, Lambert A, Montastruc JL. Pancréatites d’origine médicamenteuse. Revue des notifications spontanées en France. Drug-induced pancreatitis. A review of French spontaneous reports. Rev Med Int. 2015 ;36:573-78.

Courrier V, Fournier JP, Sommet A, Montastruc JL, Poutrain JC. Parenteral anticoagulants use in general practice : a cross-sectional study in south western France. Clin Appl Thromb Hemost. 2015 ;21:319-24.

Egron A, Olivier-Abbal P, Gouraud A, Babai S, Combret S, Montastruc JL, Bondon-Guitton E. Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports. Targ Oncol. 2015 ;10:229-34.

Fournier JP, Yin H, Nessim SJ, Montastruc JL, Azoulay. Tramadol for non-cancer pain and the risk of hyponatremia. Am J Med. 2015 ;128:418-425.

Fournier JP, Azoulay L, Yin H, Montastruc JL, Suissa S. Tramadol Use and the Risk of Hospitalization for Hypoglycemia in Patients With Noncancer Pain. JAMA Intern Med. 2015 ;175:186-93.

Laccourreye O, Werner A, Giroud JP, Couloigner V, Bonfils P, Bondon-Guitton E. Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 ;132:31-4.

Lacroix I. Médicaments et allaitement. Duel effets pour bébé ? Science et santé. 2015 ;23:36.

Linselle M, Montastruc F, Jantzen H, Valnet-Rabier MB, Haramburu F, Coquerel A, Gouraud A, Perault-Pochat MC, Bagheri H, Montastruc JL. Drugs and Sleep Apneas ? A review of the French Pharmacovigilance database.Therapie. 2015 ;70:347-50.

Montastruc F, Rieu J, Letamendia C, Montastruc JL, Pathak A, Schmitt L. Measurement of QT interval and serotoninergic reuptake inhibitor antidepressants : a study in a university psychiatric hospital. L’Encéphale. 2015 ;41:282-283.

Montastruc F, Rouanet S, Gardette V, Rousseau V, Bagheri H, Montastruc JL. Atropinic burden of prescriptions forms in patients with Alzheimer disease : a cross-sectional study in a French PharmacoVigilance Database. Eur J Clin Pharmacol. 2015 ;71:891-5.

Montastruc F, Palmaro A, Bagheri H, Schmitt L, Montastruc JL, Lapeyre-Mestre M. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes : A pharmacoepidemiological-pharmacodynamic study in VigiBase. Eur Neuropsychopharmacol. 2015 ;25:1556-65.

Montastruc JL, Rousseau V, Chebane L, Abadie D, Bondon-Guitton E, Durrieu G, Montastruc F, Bagheri H. Hemorrhagic effects of oral anticoagulants : a comparative study between vitamin K antagonists (VKA) and direct oral anticoagulants (DOA). Eur J Clin Pharmacol. 2015 ;71:1283-84.

Moulis F, Moulis G, Balardy L, Gérard S, Sourdet S, Rougé-Bugat M, Lapeyre-Mestre M, Montastruc JL, Rolland Y, Vellas B. Searching for a Polypharmacy Threshold Associated With Frailty. J Am Med Dir Assoc. 2015 ;16:259-61.

Moulis F, Moulis G, Balardy L, Gérard S, Montastruc F, Sourdet S, Rougé-Bugat M, Lapeyre-Mestre M, Montastruc J, Rolland Y, Vellas B. Exposure to Atropinic Drugs and Frailty Status. J Am Med Dir Assoc. 2015 ;16:253-7.

Moulis G, Lapeyre-Mestre M, Mahévas M, Montastruc JL, Sailler L. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France. Am J Hematol. 2015 ;90:301-5.

Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc JL, Sailler L. French health insurance databases : What interest for medical research ? Rev Med Interne. 2015 ;36:411-17.

Moulis G, Lapeyre-Mestre M, Montastruc JL, Sailler L. Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study. Autoimmunity Reviews. 2015 ;14:168-73.

Moulis G, Audemard-Verger A, Arnaud L, Luxembourger C, Montastruc F, Gaman AM, Svenungsson E, Ruggeri M, Mahevas M, Gerfaud-Valentin M, Brainsky A, Michel M, Godeau B, Laurent G, Lapeyre-Mestre M, Sailler L. Thrombosis in Immune Thrombocytopenia Patients with Antiphospholipid Antibodies : A Meta-Analysis. Blood. 2015 ;126:1051.

Nguyen TTL, Palmaro A, Montastruc F, Lapeyre-Mestre M, Moulis G. Signal for Thrombosis with Eltrombopag and Romiplostim : A Disproportionality Analysis of Spontaneous Reports Within VigiBase®. Drug Saf. 2015 ;38:1179-86.

Palmaro A, Bissuel R, Renaud N, Durrieu G, Escourrou B, Oustric S, Montastruc JL, Lapeyre-Mestre M. Off-label prescribing in pediatric outpatients. Pediatrics. 2015 ;135:49-58.

Parant O, Deudon R, Benevent J, Viard C, Damase-Michel C, Guyard-Boileau B. Use of calcium channel blockers (CCB) for tocolysis in France and abroad. J Gynecol Obstet Biol Reprod (Paris). 2015 Apr ;44(4):312-23.

Pugnet G, Sailler L, Bourrel R, Montastruc JL, Lapeyre-Mestre M. Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis ? Results from a French Population-based Study. J Rheumatol. 2015 ;42:316-22.

Saliba L, Mondoly P, Duparc A, Bura-Rivière A, Maury P, Calmels V, Sallerin B, Pathak A, Montastruc JL, Bagheri H. Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation. Thérapie. 2015 ;70:485-92.

Thorel J, Civade E, Quintyn JC, Cestac P, Montastruc JL, Bagheri H. Ischaemic stroke after exposure to aflibercept : interaction with vitamin K antagonist and/or direct pharmacodynamic effect ? J Clin Pharm Ther. 2015 ;40:477-79.